Literature DB >> 25324672

Intravenous Immunoglobulin Therapy for Persistent Pemphigoid Gestationis with Steroid Induced Iatrogenic Cushing's Syndrome.

Bum Joon Ko1, Kyu Uang Whang1.   

Abstract

Entities:  

Year:  2014        PMID： 25324672      PMCID： PMC4198607          DOI： 10.5021/ad.2014.26.5.661

Source DB:  PubMed          Journal:  Ann Dermatol        ISSN： 1013-9087            Impact factor:   1.444


× No keyword cloud information.
  4 in total

1.  Accuracy of indirect immunofluorescence on sodium chloride-split skin in the differential diagnosis of bullous pemphigoid and epidermolysis bullosa acquisita.

Authors:  Baoqi Yang; Chong Wang; Shengli Chen; Xuechao Chen; Guizhi Zhou; Hongqing Tian; Meiling Yu; Dizhan Zhang; Zhongxiang Shi; Furen Zhang
Journal:  Indian J Dermatol Venereol Leprol       Date:  2011 Nov-Dec       Impact factor: 2.545

2.  Clinical experience in pemphigoid gestationis: report of 10 cases.

Authors:  Luis A Castro; Ryan B Lundell; Patricia K Krause; Lawrence E Gibson
Journal:  J Am Acad Dermatol       Date:  2006-09-14       Impact factor: 11.527

3.  High-dose intravenous immune globulin for the treatment of autoimmune blistering diseases: an evaluation of its use in 14 cases.

Authors:  K E Harman; M M Black
Journal:  Br J Dermatol       Date:  1999-05       Impact factor: 9.302

Review 4.  Intravenous immunoglobulin in the treatment of autoimmune bullous dermatoses: an update.

Authors:  Annette Czernik; Siavash Toosi; Jean-Claude Bystryn; Sergei A Grando
Journal:  Autoimmunity       Date:  2011-09-19       Impact factor: 2.815
  4 in total
  2 in total

1.  Pemphigoid gestationis successfully treated with intravenous immunoglobulin.

Authors:  Filipa Tavares Almeida; Rita Sarabando; Joana Pardal; Celeste Brito
Journal:  BMJ Case Rep       Date:  2018-04-07

Review 2.  Pruritus in Pregnancy.

Authors:  Aleksandra A Stefaniak; Manuel P Pereira; Claudia Zeidler; Sonja Ständer
Journal:  Am J Clin Dermatol       Date:  2022-02-21       Impact factor: 7.403
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.